Related Experiment Video
Updated: Jun 21, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity
Barbara Müller1, Maria Anders, Hisashi Akiyama
1Department of Virology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, D-69120 Heidelberg, Germany. barbara_mueller@med.uni-heidelberg.de
Low protease inhibitor concentrations impair human immunodeficiency virus (HIV) polyprotein processing, reducing particle infectivity. Partially processed Gag intermediates can dominantly affect HIV maturation, highlighting the CA-SP1 cleavage site
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Protease inhibitors (PI) are crucial for human immunodeficiency virus (HIV) treatment by blocking viral polyprotein processing.
- A direct quantitative link between Gag processing impairment and virion infectivity at low PI concentrations is not well understood.
Purpose of the Study:
- To investigate the consequences of partial polyprotein processing on HIV particle infectivity.
- To analyze the impact of partially processed Gag forms on wild-type HIV maturation and replication.
Main Methods:
- Producing HIV particles with limiting PI concentrations.
- Co-transfecting wild-type proviral plasmids with Gag cleavage site mutants.
- Analyzing viral entry, reverse transcriptase activity, and post-reverse transcription replication steps.
Main Results:
- Low PI concentrations induced subtle Gag processing changes, significantly reducing particle infectivity.
- Partially processed Gag intermediates exhibited a trans-dominant effect on wild-type HIV maturation.
- The CA-SP1 cleavage site was critical for this trans-dominant effect and Gag processing.
Conclusions:
- Low levels (<5%) of Gag processing intermediates can dominantly inhibit HIV particle maturation.
- The CA-SP1 cleavage is particularly important for HIV maturation.
- These findings may explain PI efficacy in vivo and inform antiviral drug mechanisms, including bevirimat.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Size and Structure of Viral Genomes
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Retroviruses
Retrovirus Life Cycles

